Camostat
Camostat is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target trypsin-1, transmembrane protease serine 2, and prostasin.
Trade Name | |
---|---|
Common Name | Camostat |
ChEMBL ID | CHEMBL590799 |
Indication | |
Drug Class | Enzyme inhibitors: proteolytic enzyme inhibitors |